ArrowMark Partners
North America, Colorado, United States, Denver
Description
ArrowMark Partners manages assets on behalf of a diverse group of institutional clients and asset allocators.
Investor Profile
ArrowMark Partners has made 73 investments, with 3 in the past 12 months and 12% as lead.
Stage Focus
- Series B (30%)
- Series C (27%)
- Series E (8%)
- Post Ipo Equity (8%)
- Series D (8%)
- Series Unknown (5%)
- Series A (4%)
- Convertible Note (3%)
- Series G (3%)
- Series F (3%)
Country Focus
- United States (96%)
- France (1%)
- United Kingdom (1%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Bermuda (1%)
Industry Focus
- Biotechnology
- Health Care
- Life Science
- Pharmaceutical
- Therapeutics
- Biopharma
- Medical
- Genetics
- Medical Device
- Software
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
